Turkovac

BIOLOGICAL4 trials

Sponsors

Health Institutes of Turkey

Conditions

COVID-19SARS CoV 2 InfectionSars-CoV-2 Infection

Phase 2

Booster Vaccination Against COVID-19

CompletedNCT04979949

Health Institutes of TurkeyCOVID-19, Sars-CoV-2 Infection

Start: 2021-07-12End: 2022-06-06Updated: 2023-11-29

Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent

CompletedNCT05230940

Health Institutes of TurkeyCOVID-19, Sars-CoV-2 Infection

Start: 2022-02-18End: 2024-02-08Updated: 2024-05-28

Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women

WithdrawnNCT06997653

Health Institutes of TurkeyCOVID-19, SARS CoV 2 Infection

Start: 2024-01-01End: 2024-01-01Updated: 2025-05-30

Phase 3

Phase 3 Booster Vaccination Against COVID-19

CompletedNCT05077176

Health Institutes of TurkeyCOVID-19, Sars-CoV-2 Infection

Start: 2021-10-08End: 2024-02-05Updated: 2024-02-29

Related Papers

Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

Vaccines2023-07-121 citations

Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

Human Vaccines & Immunotherapeutics2022-10-3116 citations